Back

Rivaroxaban combined with spironolactone attenuates cardiovascular remodeling due to hypoxia in pulmonary arterial hypertension

26 August 2018 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Best Posters 3 - Best Posters in cardiovascular remodelling Anticoagulants ESC Premium Access ESC Congress 2018

About the speaker

Photo
Professor Tetsuya Hayashi

Osaka Medical College, Takatsuki (Japan)

4 More presentations in this session

Presentation thumbnail
Presentation thumbnail
Professor M. Fernandez-Alfonso (Madrid, ES)
Abstract Slides
Presentation thumbnail
Mrs M. Lachaux (Rouen, FR)
Abstract Slides
Presentation thumbnail
Professor A. Scridon (Targu Mures, RO)
Abstract Slides

Access the full session

Session thumbnail
Best Posters 3 - Best Posters in cardiovascular remodelling

The Event

Event poster

ESC Congress 2018

26 August 2018 14:00 CET
You may be interested in
thumbnail
Congress Session
Pulmonary hypertension & acute arrhythmias are cardiac care challenges. How to effectively treat them with drugs
25 August 2023
thumbnail
Congress Presentation
Right ventricular remodeling as unfavorable feature in patients with chronic obstructive pulmonary disease combined with hypertension
29 June 2021
thumbnail
Congress Presentation
Investigating the effect of colchicine treatment on pulmonary arterial hypertension in a rat model
22 May 2023
thumbnail
Congress Session
Don’t forget to look right
18 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources